Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...
Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...
Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...
Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...
Cencora COR is slated to report first-quarter fiscal 2025 results on Feb. 05, before market open. In the last reported ...
The Trump administration’s moves to trim government spending pose a short-term “understated risk” for companies all across ...
In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...
Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.
Shares of Cencora Inc. COR shed 1.12% to $251.57 Tuesday, on what proved to be an all-around positive trading session for the ...
CONSHOHOCKEN, Pa., January 08, 2025--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025, prior to ...
American Express, Cencora and Tempur Sealy International have been highlighted in this Screen of The Week article.